Thompson Investment Management’s Gilead Sciences GILD Stock Holding History

Thompson Investment Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-444	Closed	-$41K	–	489
2024 Q4	$41K	Hold	444	–	–	0.01%	294
2024 Q3	$37.2K	Hold	444	–	–	0.01%	293
2024 Q2	$30.5K	Hold	444	–	–	﹤0.01%	303
2024 Q1	$32.5K	Hold	444	–	–	﹤0.01%	309
2023 Q4	$36K	Hold	444	–	–	0.01%	256
2023 Q3	$33.3K	Hold	444	–	–	0.01%	262
2023 Q2	$34.2K	Hold	444	–	–	0.01%	269
2023 Q1	$36.8K	Buy	+444	New	+$36.8K	0.01%	271

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Thompson Investment Management's GILD Position: Q1 2025 in Review

Thompson Investment Management sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 444 shares — an estimated $41K sold.

Thompson Investment Management first reported a position in GILD in Q1 2023 and held it in 8 quarters. The position peaked at $41K in Q4 2024. 2,013 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

Thompson Investment Management reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
Thompson Investment Management sold 444 Gilead Sciences shares in Q1 2025, an estimated $41K.
Thompson Investment Management first reported a position in Gilead Sciences in Q1 2023 and held it in 8 quarters.
Thompson Investment Management's Gilead Sciences position peaked at $41K in Q4 2024.
2,013 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Thompson Investment Management's 13F filing for Q1 2025, filed 15 Apr 2025.